Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversa is currently a new star in the field of anti-cancer, which is used oral···【more】
Release date：2024-08-27Recommended：214
Alpelisib was approved by the FDA in 2019 as a PIK3CA kinase inhibitor in combin···【more】
Release date：2024-08-27Recommended：235
Balversa is a new oral anti-cancer star on the market, showing excellent tumor s···【more】
Release date：2024-08-27Recommended：213
Alpelisib was approved by the FDA in May 2019 for use in combination with fulves···【more】
Release date：2024-08-27Recommended：262
As a PIK3CA kinase inhibitor, Alpelisib plays an important role in the relations···【more】
Release date：2024-08-27Recommended：250
Balversais an oral anti-cancer star targeting FGFR mutations, which has a signif···【more】
Release date：2024-08-27Recommended：296
Balversa is an oral anticancer drug that specializes in FGFR mutant tumors, such···【more】
Release date：2024-08-27Recommended：282
Balversa is an oral anticancer drug used for the treatment of locally advanced o···【more】
Release date：2024-08-27Recommended：238
Accurately understanding the dosage of Balversa is the key to achieving the best···【more】
Release date：2024-08-27Recommended：191
Mastering the correct use of Balversais the first step to ensuring efficacy and ···【more】
Release date：2024-08-27Recommended：212
In-depth analysis of the treatment of Balversa, the primary concern is its recom···【more】
Release date：2024-08-27Recommended：278
Alpelisib effectively treats patients with HR/HER2- breast cancer harboring PIK3···【more】
Release date：2024-08-26Recommended：276
